World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $124.65bn | 31.33 | n/a |
REGNRegeneron Pharmaceuticals | $110.51bn | 28.6 | n/a |
MRNAModerna | $57.87bn | n/a | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
LONNLonza AG | CH₣36.52bn | 35.17 | 0.79% |
IQVIqvia Holdings | $39.94bn | 28.47 | n/a |
068270Celltrion | KR₩39tn | 69.94 | 0.26% |
ICLRIcon | $26.40bn | 35.3 | n/a |
BNTXBioNTech SE | $23.85bn | 185.07 | n/a |
ARGXargenx SE | €21.07bn | n/a | n/a |
ALNYAlnylam Pharmaceuticals | $19.33bn | n/a | n/a |
GMABGenmab A/S | DKK125.74bn | 23.31 | n/a |
NBIXNeurocrine Biosciences | $13.58bn | 36.71 | n/a |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
MEDPMedpace Holdings | $12.43bn | 40.88 | n/a |
TECHBIO-TECHNE | $12.23bn | 57.79 | 0.41% |
UTHRUnited Therapeutics | $12.20bn | 12.98 | n/a |
SRPTSarepta Therapeutics | $11.66bn | n/a | n/a |
CRLCharles River Laboratories International | $11.06bn | 23 | n/a |
QGENQiagen NV | $9.95bn | 26.92 | n/a |